7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2009-09-30 2009-06-30 2009-03-31 2008-09-30 2008-06-30 2008-03-31 2007-09-30 2007-06-30 2007-03-31 2006-09-30 2006-06-30 2006-03-31 2005-09-30 2005-06-30 2005-03-31 2004-09-30 2004-06-30 2004-03-31 
      
    		                                                                         
      cash flows from operations
    		  -193,000,000 488,000,000 253,000,000 115,000,000 163,000,000 531,000,000 365,000,000 351,000,000 479,000,000 439,000,000 290,000,000 274,000,000 208,000,000 693,000,000 675,000,000 477,000,000 377,000,000 712,000,000 510,000,000 374,000,000 272,000,000 829,000,000 664,000,000 264,000,000 347,000,000  544,000,000 343,000,000 389,000,000  251,000,000 265,000,000 272,000,000  130,000,000 1,212,000,000 3,380,000,000  1,000,000 332,000,000 430,000,000  468,000,000 520,000,000 556,000,000  544,000,000 590,000,000 552,000,000  583,000,000 661,000,000 588,000,000 532,000,000 589,000,000 518,000,000          -114,000,000 554,000,000 224,000,000   -55,000,000 
      net income
    		-46,000,000 91,000,000 126,000,000 -510,000,000 144,000,000 -311,000,000 39,000,000 246,000,000 2,511,000,000 -139,000,000 45,000,000 185,000,000 -2,934,000,000 255,000,000 73,000,000 242,000,000 452,000,000 301,000,000 300,000,000 171,000,000 359,000,000 247,000,000 333,000,000 -19,000,000 340,000,000                                                 
      less: income from discontinued operations, net of tax
    		5,000,000 -31,000,000 62,000,000 -22,000,000    173,000,000 2,460,000,000                                                                 
      income from continuing operations
    		-51,000,000 122,000,000 64,000,000 -488,000,000 434,000,000 -311,000,000 39,000,000 73,000,000 51,000,000                                                                189,000,000 
      adjustments to reconcile net income to cash flows from operations:
    		                                                                         
      depreciation and amortization
    		237,000,000 257,000,000 247,000,000 245,000,000 129,000,000 288,000,000 335,000,000 324,000,000 311,000,000 309,000,000 319,000,000 334,000,000 334,000,000 355,000,000 380,000,000 245,000,000 206,000,000 222,000,000 217,000,000 213,000,000 209,000,000 202,000,000 199,000,000 209,000,000 187,000,000                                                148,000,000 
      deferred income taxes
    		50,000,000 -23,000,000 -142,000,000 -126,000,000 -1,000,000 -66,000,000 -69,000,000 98,000,000 -441,000,000 -106,000,000 -50,000,000 -51,000,000 -87,000,000 -32,000,000 -55,000,000 -48,000,000 -62,000,000 -11,000,000 -25,000,000 -43,000,000 -22,000,000 -6,000,000 -17,000,000 -265,000,000 10,000,000                                                10,000,000 
      stock compensation
    		35,000,000 35,000,000 10,000,000 39,000,000 22,000,000 28,000,000 25,000,000 30,000,000 41,000,000 37,000,000 25,000,000 32,000,000 45,000,000 45,000,000 32,000,000 53,000,000 34,000,000 37,000,000 22,000,000 33,000,000 33,000,000 35,000,000 29,000,000 30,000,000 35,000,000                                                 
      net periodic pension and other postretirement costs
    		-8,000,000 -8,000,000 -8,000,000 -7,000,000 -10,000,000 -6,000,000 -5,000,000 -7,000,000 -4,000,000 -4,000,000 -4,000,000  14,000,000 14,000,000 14,000,000  26,000,000 25,000,000 26,000,000                                                       
      other long-lived asset impairments
    		0 2,000,000 22,000,000 2,000,000 31,000,000   9,000,000                                                                  
      other
    		2,000,000 14,000,000 6,000,000 21,000,000 -4,000,000 15,000,000 9,000,000 32,000,000 14,000,000 17,000,000 14,000,000 23,000,000 6,000,000 -29,000,000 -12,000,000 46,000,000 36,000,000 -4,000,000 14,000,000 32,000,000 27,000,000 14,000,000 13,000,000 25,000,000 69,000,000                                                23,000,000 
      changes in balance sheet items:
    		                                                                         
      accounts receivable
    		-4,000,000 -66,000,000 26,000,000 -18,000,000 6,000,000 -160,000,000 137,000,000 -121,000,000 -47,000,000 -34,000,000 136,000,000 -30,000,000 -159,000,000 -110,000,000 153,000,000 -42,000,000 -86,000,000 -93,000,000 51,000,000 0 -101,000,000 35,000,000 -60,000,000 -42,000,000                                                 -99,000,000 
      inventories
    		-81,000,000 -157,000,000 -122,000,000 -21,000,000 49,000,000 -25,000,000 -204,000,000 102,000,000 -7,000,000 -28,000,000 -181,000,000 49,000,000 -102,000,000 -203,000,000 -105,000,000 112,000,000 6,000,000 -26,000,000 -129,000,000 143,000,000 -44,000,000 -178,000,000 -83,000,000 92,000,000 3,000,000                                                -68,000,000 
      prepaid expenses and other current assets
    		-42,000,000 34,000,000 -24,000,000 -64,000,000 -17,000,000 -34,000,000 -10,000,000 4,000,000 -5,000,000 0 -39,000,000 59,000,000 -31,000,000 -54,000,000 -13,000,000 10,000,000 -27,000,000 -26,000,000 2,000,000                                                       
      accounts payable
    		-57,000,000 5,000,000 16,000,000 109,000,000 -61,000,000 -67,000,000 131,000,000 -29,000,000 -21,000,000 0 157,000,000 -160,000,000 -7,000,000 86,000,000 5,000,000 90,000,000 23,000,000 -31,000,000 22,000,000                                                       
      accrued expenses and other current liabilities
    		182,000,000 -8,000,000 -143,000,000 236,000,000 -27,000,000 25,000,000 -190,000,000 40,000,000 212,000,000 67,000,000 93,000,000 -23,000,000 -19,000,000 -10,000,000 -221,000,000 17,000,000 100,000,000 115,000,000 -124,000,000                                                       
      cash flows from (used in) operations - continuing operations
    		237,000,000                                                                         
      cash flows from (used in) operations - discontinued operations
    		0                                                                         
      cash flows from (used in) operations
    		237,000,000                                                                         
      cash flows from investing activities
    		  3,265,000,000 -205,000,000 -164,000,000 -91,000,000 -166,000,000 -230,000,000 3,786,000,000 -173,000,000 -170,000,000 -256,000,000 -184,000,000 -187,000,000 -304,000,000 -10,267,000,000 -207,000,000 -188,000,000 -538,000,000 -264,000,000 -157,000,000 -154,000,000 -604,000,000 -421,000,000 -217,000,000 -264,000,000 -198,000,000  -157,000,000 -156,000,000 -155,000,000  -131,000,000 -156,000,000 -123,000,000  -167,000,000 -168,000,000 -184,000,000  363,000,000 -500,000,000 -521,000,000 -573,000,000 -481,000,000 -423,000,000 -421,000,000 -488,000,000 -398,000,000 -347,000,000 -292,000,000 -399,000,000 -259,000,000 -264,000,000 -239,000,000 -247,000,000 -216,000,000 -171,000,000 -251,000,000 -207,000,000 -157,000,000 -166,000,000 -165,000,000 -93,000,000 -138,000,000 -122,000,000 -76,000,000 -165,000,000     -77,000,000 
      capital expenditures
    		-111,000,000 -140,000,000 -122,000,000 -132,000,000 -22,000,000 -116,000,000 -176,000,000 -190,000,000 -174,000,000 -156,000,000 -172,000,000 -200,000,000 -168,000,000 -171,000,000 -140,000,000 -235,000,000 -179,000,000 -158,000,000 -171,000,000 -237,000,000 -156,000,000 -144,000,000 -172,000,000 -191,000,000 -153,000,000                                                -89,000,000 
      free cash flows
    		                                                                         
      acquisitions of developed technology and investments
    		0   -5,000,000 -2,000,000 -1,000,000 -6,000,000                                                                   
      proceeds from sale of marketable equity securities
    		   0 0 18,000,000 16,000,000                                                                   
      other investing activities
    		0 34,000,000 -2,000,000 8,000,000 0   7,000,000 14,000,000 0 5,000,000 1,000,000 0 0 10,000,000 7,000,000 18,000,000 6,000,000 14,000,000 1,000,000 12,000,000 0 11,000,000 2,000,000 11,000,000                                                 
      cash flows from (used in) investing activities - continuing operations
    		-111,000,000                                                                         
      cash flows from (used in) investing activities - discontinued operations
    		0                                                                         
      cash flows from (used in) investing activities
    		-111,000,000                                                                         
      cash flows from financing activities
    		  -3,226,000,000 141,000,000 -146,000,000 -936,000,000 -140,000,000 -2,935,000,000 -62,000,000 -120,000,000 -372,000,000 -119,000,000 -302,000,000 -469,000,000 -548,000,000 9,276,000,000 -324,000,000 -349,000,000 -358,000,000 -1,143,000,000 -111,000,000 -261,000,000 1,170,000,000 -116,000,000 -354,000,000 173,000,000 795,000,000    -87,000,000  0    1,580,000,000 0 61,000,000  121,000,000 5,847,000,000 900,000,000  7,000,000 2,000,000 32,000,000  9,000,000 3,481,000,000 8,000,000  1,010,000,000 0 12,000,000 501,000,000 3,000,000 358,000,000 9,000,000 505,000,000 4,000,000 16,000,000 42,000,000 15,000,000 624,000,000 8,000,000 75,000,000 411,000,000 -379,000,000 20,000,000   -150,000,000 
      repayments of debt
    		0 -680,000,000 -2,825,000,000 -1,830,000,000 -3,000,000 -809,000,000 -15,000,000 -2,281,000,000 -211,000,000 -139,000,000 -3,000,000 -1,000,000 -204,000,000 -345,000,000 -404,000,000 -2,416,000,000                                                          
      repayments of debt with original maturities of three months or less
    		0                                                                         
      cash dividends on common stock
    		-87,000,000 -87,000,000 -87,000,000 -147,000,000 -148,000,000 -148,000,000 -147,000,000 -147,000,000 -147,000,000 -146,000,000 -146,000,000 -146,000,000 -146,000,000 -141,000,000 -140,000,000 -140,000,000 -141,000,000 -124,000,000 -125,000,000 -125,000,000 -125,000,000 -112,000,000 -111,000,000 -113,000,000 -112,000,000                                                 
      proceeds from stock issued under employee benefit plans
    		9,000,000 6,000,000 10,000,000 8,000,000 11,000,000 12,000,000 40,000,000 9,000,000 32,000,000 18,000,000 36,000,000 13,000,000 26,000,000 22,000,000 66,000,000 52,000,000 42,000,000 45,000,000 48,000,000 22,000,000 29,000,000 85,000,000 66,000,000 22,000,000 72,000,000                                                31,000,000 
      payments of contingent liabilities
    		                                                                         
      other financing activities
    		7,000,000 -1,000,000 -24,000,000 -16,000,000 -6,000,000 9,000,000 -18,000,000 -3,000,000 -1,000,000 -51,000,000 -10,000,000 -10,000,000 -21,000,000 -5,000,000 -25,000,000 -7,000,000 4,000,000 -9,000,000 -28,000,000 -4,000,000 -14,000,000 -9,000,000 -25,000,000 -6,000,000 -5,000,000                                                 
      cash flows from (used in) financing activities
    		-81,000,000                                                                         
      effect of foreign exchange rate changes on cash, cash equivalents and restricted cash - continuing operations
    		-5,000,000 52,000,000 36,000,000                                                                       
      effect of foreign exchange rate changes on cash, cash equivalents and restricted cash - discontinued operations
    		                                                                         
      increase in cash, cash equivalents and restricted cash
    		40,000,000 -608,000,000 -118,000,000 334,000,000 -16,000,000   -2,594,000,000        -305,000,000 121,000,000 -46,000,000 -550,000,000 -630,000,000 272,000,000                                                     
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 2,414,000,000  0 0 3,198,000,000  0 0 1,722,000,000  0 0 2,956,000,000  0 0 3,736,000,000  0                                                     
      cash, cash equivalents and restricted cash at end of period
    		40,000,000 -608,000,000 2,296,000,000  -16,000,000 -934,000,000 3,030,000,000  4,066,000,000 49,000,000 1,677,000,000  -252,000,000 -443,000,000 2,299,000,000  121,000,000 -46,000,000 3,186,000,000  272,000,000                                                     
      less cash and cash equivalents of discontinued operations
    		   -10,000,000                                                                      
      cash, cash equivalents and restricted cash of continuing operations
    		40,000,000 -608,000,000 2,296,000,000 344,000,000                                                                      
      cash and cash equivalents
    		40,000,000 -608,000,000 2,294,000,000 344,000,000 -675,000,000 -931,000,000 3,026,000,000 -2,594,000,000 4,066,000,000 49,000,000 1,673,000,000  -251,000,000 -442,000,000 2,294,000,000  122,000,000 -46,000,000 3,182,000,000  274,000,000                                                     
      restricted cash included in other non-current assets
    		0 0 2,000,000  1,000,000 -3,000,000 4,000,000                                                                   
      cash and cash equivalents of discontinued operations
    		                                                                         
      cash, cash equivalents and restricted cash
    		40,000,000 -608,000,000 2,296,000,000 344,000,000 -674,000,000 -934,000,000 3,030,000,000 -2,594,000,000 4,066,000,000 49,000,000 1,677,000,000  -252,000,000 -443,000,000 2,299,000,000  121,000,000 -46,000,000 3,186,000,000  272,000,000                                                     
      cash flows from operations - continuing operations
    		  -99,000,000  98,000,000 115,000,000 163,000,000  317,000,000                                                                 
      cash flows from operations - discontinued operations
    		  -94,000,000      48,000,000                                                                 
      cash flows from investing activities - continuing operations
    		  -124,000,000 -129,000,000 -24,000,000 -91,000,000 -166,000,000 -183,000,000 -163,000,000                                                                 
      cash flows from investing activities - discontinued operations
    		  3,389,000,000 -76,000,000    -47,000,000 3,949,000,000                                                                 
      net decreases in debt with original maturities of three months or less
    		  -300,000,000       198,000,000 -249,000,000    -45,000,000      -1,000,000                                                     
      pension settlement and curtailment (gains) losses
    		                                                                         
      goodwill impairments
    		           27,000,000                                                              
      intangible asset impairments
    		       0    12,000,000        0 0                                                     
      loss on product divestiture arrangement
    		           0                                                              
      reclassification of cumulative translation loss to earnings
    		           0                                                              
      loss on subsidiary liquidation
    		                                                                         
      cash flows from operations – continuing operations
    		               693,000,000 675,000,000 477,000,000 377,000,000 712,000,000 510,000,000 374,000,000 274,000,000 829,000,000 664,000,000                                                 
      cash flows from operations – discontinued operations
    		                   0 0 0 -2,000,000 0 0                                                 
      increase in short term debt
    		                                                                         
      net (decreases) increases in debt with original maturities of three months or less
    		                                                                         
      purchases of treasury stock
    		           0    0 -35,000,000 -312,000,000 -253,000,000     -241,000,000 -309,000,000                                                -11,000,000 
      effect of foreign exchange rate changes on cash, cash equivalents and restricted cash
    		     -22,000,000 -25,000,000 40,000,000 -23,000,000 -9,000,000 18,000,000 54,000,000 -56,000,000 -61,000,000 -13,000,000 -7,000,000 -23,000,000 14,000,000 -31,000,000 65,000,000 30,000,000                                                     
      cash, cash equivalents and restricted cash at beginning of year
    		                                                                         
      cash, cash equivalents and restricted cash at end of year
    		                                                                         
      as of december 31
    		                                                                         
      restricted cash included in prepaid expenses and other current assets
    		       0 0 0 4,000,000  -1,000,000 -1,000,000 5,000,000  -1,000,000 0 4,000,000  -2,000,000                                                     
      net increases in debt with original maturities of three months or less
    		                                                                         
      goodwill impairment
    		                                                                         
      decrease in cash, cash equivalents and restricted cash
    		      -168,000,000   49,000,000 -45,000,000  -252,000,000 -443,000,000 -657,000,000                                                           
      adjustments to reconcile net income to cash flows operations:
    		                                                                         
      losses on debt extinguishments
    		                                                                         
      acquisitions, net of cash acquired, and investments
    		       0 -3,000,000 0 -3,000,000 -57,000,000 -16,000,000 -16,000,000 -174,000,000 -10,039,000,000 -46,000,000 -36,000,000 -381,000,000  -13,000,000                                                     
      issuances of debt
    		               11,853,000,000     0 0 1,240,000,000  0                                                87,000,000 
      debt issuance costs
    		               -61,000,000                                                          
      property, plant and equipment impairments
    		                                                                         
      adjustments to reconcile net income to net cash from operating activities:
    		                                                                         
      net periodic pension benefit and other postretirement costs
    		                     20,000,000 20,000,000 14,000,000 1,000,000                                                 
      settlement of interest rate derivative contracts
    		                                                                         
      net increase in debt with original maturities of three months or less
    		               -5,000,000 200,000,000                                                         
      net increases (decreases) in debt with original maturities of three months or less
    		            75,000,000                                                             
      pension settlement charges
    		                                                                         
      loss on debt extinguishment
    		                                                                         
      intangible asset impairment
    		                       0 0                                                 
      adjustments to reconcile income from continuing operations to net cash from operating activities:
    		                                                                         
      income from discontinued operations, net of tax
    		                                                                         
      accounts payable and accrued liabilities
    		                   107,000,000 84,000,000 62,000,000 -110,000,000 37,000,000 59,000,000                                                -196,000,000 
      acquisitions and investments, net of cash acquired
    		                      -443,000,000                                                   
      issuances of long-term debt
    		                                                                         
      payments of long-term debt
    		                                                                         
      (repayments) borrowings under revolving credit facility
    		                                                                         
      effect of foreign exchange rate changes on cash and cash equivalents
    		                      -63,000,000 34,000,000 -15,000,000 -26,000,000 2,000,000                                               
      increase in cash and cash equivalents
    		                      775,000,000 326,000,000 78,000,000 1,017,000,000 76,000,000                                               
      cash and cash equivalents at beginning of period
    		                      3,335,000,000  6,000,000 0 1,832,000,000                                               
      cash and cash equivalents at end of period
    		                      4,110,000,000  84,000,000 1,017,000,000 1,908,000,000                                               
      balance at beginning of period
    		                      112,000,000                                                   
      adoption of new accounting standard
    		                      4,000,000                                                   
      charged to costs and expenses
    		                      7,000,000                                                   
      currency translation adjustments
    		                      -9,000,000                                                   
      balance at end of period
    		                      114,000,000                                                   
      borrowings under revolving credit facility
    		                                                                         
      cash and cash equivalents at beginning of year
    		                                                                         
      cash and cash equivalents at end of year
    		                                                                         
      other supplemental information
    		                                                                         
      interest paid, net of portion capitalized
    		                                                                         
      income taxes paid
    		                                   47,000,000 108,000,000 -84,000,000 429,000,000                                   
      acquisitions and investments
    		                        -75,000,000                                                 
      baxter international inc.
    		                                                                         
      condensed consolidated balance sheet
    		                                                                         
      current assets:
    		                                                                         
      total current assets
    		                                                                         
      property, plant and equipment
    		                                                                         
      goodwill
    		                                                                         
      other intangible assets
    		                                                                         
      other non-current assets
    		                                                                         
      total assets
    		                                                                         
      current liabilities:
    		                                                                         
      short-term debt
    		                                                                         
      current maturities of long-term debt and finance lease obligations
    		                                                                         
      total current liabilities
    		                                                                         
      long-term debt and finance lease obligations
    		                                                                         
      other non-current liabilities
    		                                                                         
      total liabilities
    		                                                                         
      commitments and contingencies
    		                                                                         
      equity:
    		                                                                         
      common stock, 1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares
    		                                                                         
      common stock in treasury, at cost, 170,495,859 shares
    		                                                                         
      additional contributed capital
    		                                                                         
      retained earnings
    		                                                                         
      accumulated other comprehensive income
    		                                                                         
      total baxter stockholders’ equity
    		                                                                         
      noncontrolling interests
    		                                                                         
      total equity
    		                                                                         
      total liabilities and equity
    		                                                                         
      restructuring charges
    		                                                                         
      accounts and other current receivables
    		                                                                         
      restructuring payments
    		                                                                        -37,000,000 
      non-cash investing and financing activities
    		                                                                         
      decrease in liabilities for capital expenditures
    		                         -10,000,000 57,000,000                                               
      decrease in liability for treasury stock purchases
    		                         12,000,000 11,000,000                                               
      supplemental schedule of non-cash activities
    		                                                                         
      cash flows from
    		                                                                      259,000,000   
      operations
    		                                                                         
      investing activities
    		                                                                      0   
      financing activities
    		                                                                      -259,000,000   
      supplemental schedule of non-cash investing and financing activities
    		                                                                         
      net proceeds on retained shares transactions
    		                                                                         
      payment of obligations in exchange for retained shares
    		                                   0 0 0 3,646,000,000                                   
      exchange of baxter shares with retained shares
    		                                   0 0                                     
      (increases) decreases in the accrual for capital expenditures
    		                                                                         
      effect of foreign exchange rate changes on cash and equivalents
    		                            -23,000,000 -67,000,000 25,000,000 -85,000,000 45,000,000 23,000,000 22,000,000 -50,000,000 6,000,000 -5,000,000 22,000,000 -21,000,000 -41,000,000 -28,000,000 -105,000,000 -24,000,000 -28,000,000 -20,000,000 -7,000,000                           
      increase in cash and equivalents
    		                            3,000,000 -90,000,000 -447,000,000 -123,000,000 -300,000,000   204,000,000 -33,000,000           357,000,000 -3,613,000,000   79,000,000          -668,000,000 102,000,000 -101,000,000 1,006,000,000 180,000,000 40,000,000 284,000,000     -279,000,000 
      cash and equivalents at beginning of period
    		                            0 0 3,394,000,000  0 0 2,801,000,000  0 0 2,213,000,000  0 0 2,925,000,000  0 0 2,733,000,000  0 0 3,270,000,000  0 0 2,905,000,000 0 0 2,131,000,000 0 0 2,539,000,000 0 0 2,485,000,000 0 0 841,000,000 0 0 1,109,000,000 0 -2,000,000 927,000,000 
      cash and equivalents at end of period
    		                            3,000,000 -90,000,000 2,947,000,000  -300,000,000 959,000,000 2,858,000,000  -33,000,000 419,000,000 2,211,000,000  -4,710,000,000 4,150,000,000 2,530,000,000  212,000,000 -183,000,000 2,049,000,000  -3,613,000,000 3,300,000,000 2,689,000,000  838,000,000 81,000,000 2,272,000,000 769,000,000 99,000,000 1,703,000,000 44,000,000 411,000,000 1,736,000,000 -668,000,000 102,000,000 2,384,000,000 1,006,000,000 180,000,000 881,000,000 284,000,000 322,000,000 1,106,000,000 62,000,000 112,000,000 648,000,000 
      cost of sales
    		                                                                         
      gross margin
    		                                                                         
      marketing and administrative expenses
    		                                                                         
      research and development expenses
    		                                                                         
      operating income
    		                                                                         
      other income
    		                                                                         
      cash and equivalents at beginning of year
    		                                                                         
      cash and equivalents at end of year
    		                                                                         
      as of and for the years ended december 31
    		                                                                         
      common stock
    		                                                                         
      balance, beginning and end of year
    		                                                                         
      common stock in treasury
    		                                                                         
      beginning of year
    		                                                                         
      purchases of common stock
    		                                                                         
      stock issued under employee benefit plans and other
    		                                                                         
      end of year
    		                                                                         
      dividends declared on common stock
    		                                                                         
      stock issued under employee benefit plans
    		                                                                         
      distribution of baxalta
    		                                                                         
      other comprehensive income
    		                                                                         
      total baxter shareholders’ equity
    		                                                                         
      change in noncontrolling interests
    		                                                                         
      net proceeds on the baxalta retained share transactions
    		                                                                         
      payment of obligations in exchange for baxalta retained shares
    		                                                                         
      exchange of baxter shares with baxalta retained shares
    		                                                                         
      major classes of line items constituting income from discontinued operations before income taxes
    		                                                                         
      net sales
    		                                                                         
      income from discontinued operations before income taxes
    		                                                                         
      gain on disposal of discontinued operations
    		                                                                         
      income tax expense
    		                                                                         
      other income and expense items that are not major
    		                                                                         
      decrease in cash and equivalents
    		                                  57,000,000    -2,000,000    -395,000,000    -684,000,000    -581,000,000   81,000,000 -633,000,000  99,000,000 -428,000,000   -803,000,000          62,000,000   
      net proceeds on retained share transactions
    		                                    0 1,148,000,000 3,239,000,000                                   
      total income from discontinued operations before income taxes
    		                                                                         
      total income from discontinued operations
    		                                                                         
      exercise of sigma purchase option
    		                                                                         
      balance, beginning of year and end of period
    		                                                                         
      end of period
    		                                                                         
      accumulated other comprehensive loss
    		                                                                         
      income before income taxes
    		                                                                         
      income tax (benefit) expense
    		                                                                         
      elimination of sigma noncontrolling ownership interest
    		                                                                         
      interest expense, net of capitalized interest
    		                                                                  41,000,000       
      interest income
    		                                                                  -10,000,000       
      net interest expense
    		                                                                  31,000,000       
      cash flows
    		                                                                         
      from operations
    		                                                                         
      net income attributable to baxter
    		                                                                         
      other comprehensive income attributable to baxter
    		                                                                         
      effect of currency exchange rate changes on cash and equivalents
    		                                                0 9,000,000 -18,000,000  -6,000,000 -36,000,000 2,000,000 31,000,000 -2,000,000 -76,000,000 -20,000,000 -12,000,000 50,000,000 7,000,000 -35,000,000 -9,000,000 -5,000,000 -34,000,000 -31,000,000 -13,000,000 -5,000,000 19,000,000 -26,000,000 10,000,000 3,000,000 
      other comprehensive loss attributable to baxter
    		                                                                         
      raw materials
    		                                                                         
      work in process
    		                                                                         
      finished goods
    		                                                                         
      property, plant and equipment, at cost
    		                                                                         
      accumulated depreciation and amortization
    		                                                                         
      property, plant and equipment (pp&e)
    		                                                                         
      pension benefits
    		                                                                         
      service cost
    		                                                                 -1,000,000 21,000,000       
      interest cost
    		                                                                 -1,000,000 41,000,000       
      expected return on plan assets
    		                                                                 1,000,000 -43,000,000       
      amortization of net incomees and other deferred amounts
    		                                                                         
      net periodic pension benefit cost
    		                                                                         
      opeb
    		                                                                         
      amortization of prior service credit and net income
    		                                                                         
      net periodic opeb cost
    		                                                                         
      net pension plan expense
    		                                                                 -1,000,000 40,000,000       
      net opeb plan expense
    		                                                                 -4,000,000 13,000,000       
      cash flows from operating activities
    		                                                          472,000,000 544,000,000 429,000,000 395,000,000 431,000,000 403,000,000 374,000,000 309,000,000 282,000,000       
      amortization of net income, prior service cost and transition obligation
    		                                                                 0 21,000,000       
      amortization of net income and prior service cost
    		                                                                 -2,000,000 3,000,000       
      net interest expense consisted of the following.
    		                                                                         
      net income, as reported
    		                                                                    146,000,000 176,000,000 218,000,000 -143,000,000 178,000,000 
      add:
    		                                                                         
      stock-based employee compensation expense included in reported net income, net of tax
    		                                                                         
      deduct:
    		                                                                         
      total stock-based employee compensation expense determined under the fair value method, net of tax
    		                                                                      13,000,000   
      pro forma net income
    		                                                                    158,000,000 148,000,000 232,000,000 -163,000,000 150,000,000 
      earnings per basic share
    		                                                                         
      as reported
    		                                                                    230,000 290,000 370,000 -230,000 290,000 
      pro forma
    		                                                                    240,000 250,000 400,000 -270,000 250,000 
      earnings per diluted share
    		                                                                         
      adjustments
    		                                                                         
      restructuring
    		                                                                         
      infusion pump charge
    		                                                                         
      changes in balance sheet items
    		                                                                         
      cash flows from continuing operations
    		                                                                        -54,000,000 
      cash flows from discontinued operations
    		                                                                        -1,000,000 
      acquisitions (net of cash received) and investments in and advances to affiliates
    		                                                                        -14,000,000 
      divestitures and other
    		                                                                        26,000,000 
      payments of obligations
    		                                                                         
      increase in debt with maturities of three months or less
    		                                                                        137,000,000 
      common stock cash dividends
    		                                                                        -361,000,000 
      add: stock-based employee compensation expense included in reported net income, net of tax
    		                                                                         
      deduct: total stock-based employee compensation expense determined under the fair value method, net of tax
    		                                                                     28,000,000   28,000,000 
      contributions to pension trust
    		                                                                        -54,000,000 
      redemptions of debt and lease obligations
    		                                                                        -33,000,000 
      from investing
    		                                                                         
      activities
    		                                                                         
      from financing
    		                                                                         
      supplemental schedule of non-cash investing activities
    		                                                                         
      fair value of assets acquired, net of liabilities assumed
    		                                                                         
      common stock issued at fair value
    		                                                                         
      net cash paid
    		                                                                         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.